High DGAT1 expression levels in the small intestine highlight the critical role this enzyme plays in nutrient absorption. Identification of inhibitors which predominantly inhibit DGAT1 in the gut is an attractive drug discovery strategy with anticipated benefits of reduced systemic toxicity. In this report we describe our discovery and optimization of DGAT1 inhibitors whose plasma exposure is minimized by the action of transporters, including the P-glycoprotein transporter. The impact of this unique absorption profile on efficacy in rat and dog efficacy models is presented.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025815PMC
http://dx.doi.org/10.1021/ml3000512DOI Listing

Publication Analysis

Top Keywords

dgat1 inhibitors
8
intestinally targeted
4
targeted diacylglycerol
4
diacylglycerol acyltransferase
4
dgat1
4
acyltransferase dgat1
4
inhibitors robustly
4
robustly suppress
4
suppress postprandial
4
postprandial triglycerides
4

Similar Publications

Non-dioxin-like polychlorinated biphenyls (NDL-PCBs), as well as dioxin-like PCBs, are endocrine disruptors that persist in human and animal tissues worldwide. Due to their lipophilicity and resistance to enzymatic degradation, PCBs accumulate in fat deposits contributing to the onset of endocrine and metabolic diseases. Aquaporins (AQPs) are transmembrane channel proteins that allow the transport of water and small solutes.

View Article and Find Full Text PDF

Lipid droplet formation induced by icaritin derivative IC2 promotes a combination strategy for cancer therapy.

Chin Med

December 2024

MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, China.

Background: Lipid metabolism is crucial in cancer progression. Lipid droplets (LDs) generated in cancer cells can act as protective mechanisms through alleviating lipotoxicity under stress conditions. We previously developed IC2 from the Chinese medicine icaritin as an inhibitor of stearoyl-CoA desaturase 1 (SCD1).

View Article and Find Full Text PDF

The many faces of DGAT1.

Life Sci

December 2024

Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Cracow, Poland; Laboratory of Stem Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Cracow, Poland. Electronic address:

Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) is a multifaced enzyme with a wide spectrum of substrates, from lipids through waxes to retinoids, which makes it an interesting therapeutic target. DGAT1 inhibitors are currently at various stages of preclinical and clinical trials, mostly related to metabolic diseases. Interestingly, in recent years, a growing amount of research has shown the influence of DGAT1 on immune cell metabolism and functions, highlighting its important role during infections and tumorigenesis.

View Article and Find Full Text PDF

The mechanism of DEHP-induced lipid accumulation in liver of female zebrafish.

Environ Pollut

December 2024

Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, China. Electronic address:

Diethylhexyl phthalate (DEHP) is a typical environmental pollutant and poses a potential threat to organisms by disrupting the lipid metabolism. This study found that DEHP at environmental concentrations, led to lipid accumulation in female zebrafish, as indicated by significant increases in the content of total cholesterol, triglycerides and the lipid droplets, in a concentration-dependent manner. However, how DEHP induces the lipid accumulation remains poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Lipotoxicity is harmful for metabolic health due to excess fatty acids, with palmitic acid (PA) causing more damage compared to oleic acid (OA) in liver cells.
  • The study found that PA induces lipotoxicity, ER stress, and inhibits autophagy, leading to lower levels of DGAT1, an enzyme crucial for fat synthesis, while OA does not have the same effect.
  • The research suggests that targeting DGAT1 and using PPARα agonists could offer new therapeutic strategies to mitigate the negative impacts of palmitic acid on liver health.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!